Tuesday, April 21, 2026
Yahoo Finance

Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI

R
Redacción
Newsroom · anteayer
2 min read
Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI · DevFinanciero